0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Genome Editing and Genome Engineering Market Research Report 2023
Published Date: January 2023
|
Report Code: QYRE-Auto-11P2361
Home | Market Reports | Science| Biological Sciences
Global Genome Editing Genome Engineering Market Insights and Forecast to 2028
BUY CHAPTERS

Global Genome Editing and Genome Engineering Market Research Report 2023

Code: QYRE-Auto-11P2361
Report
January 2023
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Global Genome Editing and Genome Engineering Market

Genome editing technology refers to the ability of human to "edit" the target gene, such as the deletion and addition of specific DNA fragments.
The global Genome Editing and Genome Engineering market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Genome Editing and Genome Engineering is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Genome Editing and Genome Engineering is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Genome Editing and Genome Engineering in Cell Line Engineering is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Genome Editing and Genome Engineering include Thermo Fisher Scientific, Merck, Horizon Discovery, Genscript, Sangamo Biosciences, Integrated DNA Technologies, Lonza, New England Biolabs and Origene Technologies, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Genome Editing and Genome Engineering, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Genome Editing and Genome Engineering.
The Genome Editing and Genome Engineering market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Genome Editing and Genome Engineering market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Genome Editing and Genome Engineering companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.

Key Segmentations

By Company

  • Thermo Fisher Scientific
  • Merck
  • Horizon Discovery
  • Genscript
  • Sangamo Biosciences
  • Integrated DNA Technologies
  • Lonza
  • New England Biolabs
  • Origene Technologies
  • Transposagen Biopharmaceuticals
  • Editas Medicine
  • Crispr Therapeutics
  • Tecan Life Sciences

Segment by Type

  • CRISPR
  • TALEN
  • ZFN

Segment by Application

  • Cell Line Engineering
  • Animal Genetic Engineering
  • Plant Genetic Engineering
  • Others

By Region

  • North America
  • United States
  • Canada
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Russia
  • Nordic Countries
  • Rest of Europe
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia
  • Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Genome Editing and Genome Engineering companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

Scope of Global Genome Editing and Genome Engineering Market Report

Report MetricDetails
Report NameGlobal Genome Editing and Genome Engineering Market
Base Year2022
Forecasted years2023-2029
Forecast unitsUSD
Report coverageRevenue and volume forecast, company share, competitive landscape, growth factors and trends
Geographic regions coveredNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Genome Editing and Genome Engineering Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 CRISPR
1.2.3 TALEN
1.2.4 ZFN
1.3 Market by Application
1.3.1 Global Genome Editing and Genome Engineering Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Cell Line Engineering
1.3.3 Animal Genetic Engineering
1.3.4 Plant Genetic Engineering
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Genome Editing and Genome Engineering Market Perspective (2018-2029)
2.2 Genome Editing and Genome Engineering Growth Trends by Region
2.2.1 Global Genome Editing and Genome Engineering Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Genome Editing and Genome Engineering Historic Market Size by Region (2018-2023)
2.2.3 Genome Editing and Genome Engineering Forecasted Market Size by Region (2024-2029)
2.3 Genome Editing and Genome Engineering Market Dynamics
2.3.1 Genome Editing and Genome Engineering Industry Trends
2.3.2 Genome Editing and Genome Engineering Market Drivers
2.3.3 Genome Editing and Genome Engineering Market Challenges
2.3.4 Genome Editing and Genome Engineering Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Genome Editing and Genome Engineering Players by Revenue
3.1.1 Global Top Genome Editing and Genome Engineering Players by Revenue (2018-2023)
3.1.2 Global Genome Editing and Genome Engineering Revenue Market Share by Players (2018-2023)
3.2 Global Genome Editing and Genome Engineering Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Genome Editing and Genome Engineering Revenue
3.4 Global Genome Editing and Genome Engineering Market Concentration Ratio
3.4.1 Global Genome Editing and Genome Engineering Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Genome Editing and Genome Engineering Revenue in 2022
3.5 Genome Editing and Genome Engineering Key Players Head office and Area Served
3.6 Key Players Genome Editing and Genome Engineering Product Solution and Service
3.7 Date of Enter into Genome Editing and Genome Engineering Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Genome Editing and Genome Engineering Breakdown Data by Type
4.1 Global Genome Editing and Genome Engineering Historic Market Size by Type (2018-2023)
4.2 Global Genome Editing and Genome Engineering Forecasted Market Size by Type (2024-2029)
5 Genome Editing and Genome Engineering Breakdown Data by Application
5.1 Global Genome Editing and Genome Engineering Historic Market Size by Application (2018-2023)
5.2 Global Genome Editing and Genome Engineering Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Genome Editing and Genome Engineering Market Size (2018-2029)
6.2 North America Genome Editing and Genome Engineering Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Genome Editing and Genome Engineering Market Size by Country (2018-2023)
6.4 North America Genome Editing and Genome Engineering Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Genome Editing and Genome Engineering Market Size (2018-2029)
7.2 Europe Genome Editing and Genome Engineering Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Genome Editing and Genome Engineering Market Size by Country (2018-2023)
7.4 Europe Genome Editing and Genome Engineering Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Genome Editing and Genome Engineering Market Size (2018-2029)
8.2 Asia-Pacific Genome Editing and Genome Engineering Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Genome Editing and Genome Engineering Market Size by Region (2018-2023)
8.4 Asia-Pacific Genome Editing and Genome Engineering Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Genome Editing and Genome Engineering Market Size (2018-2029)
9.2 Latin America Genome Editing and Genome Engineering Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Genome Editing and Genome Engineering Market Size by Country (2018-2023)
9.4 Latin America Genome Editing and Genome Engineering Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Genome Editing and Genome Engineering Market Size (2018-2029)
10.2 Middle East & Africa Genome Editing and Genome Engineering Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Genome Editing and Genome Engineering Market Size by Country (2018-2023)
10.4 Middle East & Africa Genome Editing and Genome Engineering Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Detail
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Genome Editing and Genome Engineering Introduction
11.1.4 Thermo Fisher Scientific Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Genome Editing and Genome Engineering Introduction
11.2.4 Merck Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.2.5 Merck Recent Development
11.3 Horizon Discovery
11.3.1 Horizon Discovery Company Detail
11.3.2 Horizon Discovery Business Overview
11.3.3 Horizon Discovery Genome Editing and Genome Engineering Introduction
11.3.4 Horizon Discovery Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.3.5 Horizon Discovery Recent Development
11.4 Genscript
11.4.1 Genscript Company Detail
11.4.2 Genscript Business Overview
11.4.3 Genscript Genome Editing and Genome Engineering Introduction
11.4.4 Genscript Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.4.5 Genscript Recent Development
11.5 Sangamo Biosciences
11.5.1 Sangamo Biosciences Company Detail
11.5.2 Sangamo Biosciences Business Overview
11.5.3 Sangamo Biosciences Genome Editing and Genome Engineering Introduction
11.5.4 Sangamo Biosciences Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.5.5 Sangamo Biosciences Recent Development
11.6 Integrated DNA Technologies
11.6.1 Integrated DNA Technologies Company Detail
11.6.2 Integrated DNA Technologies Business Overview
11.6.3 Integrated DNA Technologies Genome Editing and Genome Engineering Introduction
11.6.4 Integrated DNA Technologies Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.6.5 Integrated DNA Technologies Recent Development
11.7 Lonza
11.7.1 Lonza Company Detail
11.7.2 Lonza Business Overview
11.7.3 Lonza Genome Editing and Genome Engineering Introduction
11.7.4 Lonza Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.7.5 Lonza Recent Development
11.8 New England Biolabs
11.8.1 New England Biolabs Company Detail
11.8.2 New England Biolabs Business Overview
11.8.3 New England Biolabs Genome Editing and Genome Engineering Introduction
11.8.4 New England Biolabs Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.8.5 New England Biolabs Recent Development
11.9 Origene Technologies
11.9.1 Origene Technologies Company Detail
11.9.2 Origene Technologies Business Overview
11.9.3 Origene Technologies Genome Editing and Genome Engineering Introduction
11.9.4 Origene Technologies Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.9.5 Origene Technologies Recent Development
11.10 Transposagen Biopharmaceuticals
11.10.1 Transposagen Biopharmaceuticals Company Detail
11.10.2 Transposagen Biopharmaceuticals Business Overview
11.10.3 Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Introduction
11.10.4 Transposagen Biopharmaceuticals Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.10.5 Transposagen Biopharmaceuticals Recent Development
11.11 Editas Medicine
11.11.1 Editas Medicine Company Detail
11.11.2 Editas Medicine Business Overview
11.11.3 Editas Medicine Genome Editing and Genome Engineering Introduction
11.11.4 Editas Medicine Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.11.5 Editas Medicine Recent Development
11.12 Crispr Therapeutics
11.12.1 Crispr Therapeutics Company Detail
11.12.2 Crispr Therapeutics Business Overview
11.12.3 Crispr Therapeutics Genome Editing and Genome Engineering Introduction
11.12.4 Crispr Therapeutics Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.12.5 Crispr Therapeutics Recent Development
11.13 Tecan Life Sciences
11.13.1 Tecan Life Sciences Company Detail
11.13.2 Tecan Life Sciences Business Overview
11.13.3 Tecan Life Sciences Genome Editing and Genome Engineering Introduction
11.13.4 Tecan Life Sciences Revenue in Genome Editing and Genome Engineering Business (2018-2023)
11.13.5 Tecan Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Genome Editing and Genome Engineering Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of CRISPR
    Table 3. Key Players of TALEN
    Table 4. Key Players of ZFN
    Table 5. Global Genome Editing and Genome Engineering Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Genome Editing and Genome Engineering Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 7. Global Genome Editing and Genome Engineering Market Size by Region (2018-2023) & (US$ Million)
    Table 8. Global Genome Editing and Genome Engineering Market Share by Region (2018-2023)
    Table 9. Global Genome Editing and Genome Engineering Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 10. Global Genome Editing and Genome Engineering Market Share by Region (2024-2029)
    Table 11. Genome Editing and Genome Engineering Market Trends
    Table 12. Genome Editing and Genome Engineering Market Drivers
    Table 13. Genome Editing and Genome Engineering Market Challenges
    Table 14. Genome Editing and Genome Engineering Market Restraints
    Table 15. Global Genome Editing and Genome Engineering Revenue by Players (2018-2023) & (US$ Million)
    Table 16. Global Genome Editing and Genome Engineering Market Share by Players (2018-2023)
    Table 17. Global Top Genome Editing and Genome Engineering Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genome Editing and Genome Engineering as of 2022)
    Table 18. Ranking of Global Top Genome Editing and Genome Engineering Companies by Revenue (US$ Million) in 2022
    Table 19. Global 5 Largest Players Market Share by Genome Editing and Genome Engineering Revenue (CR5 and HHI) & (2018-2023)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Genome Editing and Genome Engineering Product Solution and Service
    Table 22. Date of Enter into Genome Editing and Genome Engineering Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Genome Editing and Genome Engineering Market Size by Type (2018-2023) & (US$ Million)
    Table 25. Global Genome Editing and Genome Engineering Revenue Market Share by Type (2018-2023)
    Table 26. Global Genome Editing and Genome Engineering Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 27. Global Genome Editing and Genome Engineering Revenue Market Share by Type (2024-2029)
    Table 28. Global Genome Editing and Genome Engineering Market Size by Application (2018-2023) & (US$ Million)
    Table 29. Global Genome Editing and Genome Engineering Revenue Market Share by Application (2018-2023)
    Table 30. Global Genome Editing and Genome Engineering Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 31. Global Genome Editing and Genome Engineering Revenue Market Share by Application (2024-2029)
    Table 32. North America Genome Editing and Genome Engineering Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 33. North America Genome Editing and Genome Engineering Market Size by Country (2018-2023) & (US$ Million)
    Table 34. North America Genome Editing and Genome Engineering Market Size by Country (2024-2029) & (US$ Million)
    Table 35. Europe Genome Editing and Genome Engineering Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 36. Europe Genome Editing and Genome Engineering Market Size by Country (2018-2023) & (US$ Million)
    Table 37. Europe Genome Editing and Genome Engineering Market Size by Country (2024-2029) & (US$ Million)
    Table 38. Asia-Pacific Genome Editing and Genome Engineering Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 39. Asia-Pacific Genome Editing and Genome Engineering Market Size by Region (2018-2023) & (US$ Million)
    Table 40. Asia-Pacific Genome Editing and Genome Engineering Market Size by Region (2024-2029) & (US$ Million)
    Table 41. Latin America Genome Editing and Genome Engineering Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 42. Latin America Genome Editing and Genome Engineering Market Size by Country (2018-2023) & (US$ Million)
    Table 43. Latin America Genome Editing and Genome Engineering Market Size by Country (2024-2029) & (US$ Million)
    Table 44. Middle East & Africa Genome Editing and Genome Engineering Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 45. Middle East & Africa Genome Editing and Genome Engineering Market Size by Country (2018-2023) & (US$ Million)
    Table 46. Middle East & Africa Genome Editing and Genome Engineering Market Size by Country (2024-2029) & (US$ Million)
    Table 47. Thermo Fisher Scientific Company Detail
    Table 48. Thermo Fisher Scientific Business Overview
    Table 49. Thermo Fisher Scientific Genome Editing and Genome Engineering Product
    Table 50. Thermo Fisher Scientific Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
    Table 51. Thermo Fisher Scientific Recent Development
    Table 52. Merck Company Detail
    Table 53. Merck Business Overview
    Table 54. Merck Genome Editing and Genome Engineering Product
    Table 55. Merck Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
    Table 56. Merck Recent Development
    Table 57. Horizon Discovery Company Detail
    Table 58. Horizon Discovery Business Overview
    Table 59. Horizon Discovery Genome Editing and Genome Engineering Product
    Table 60. Horizon Discovery Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
    Table 61. Horizon Discovery Recent Development
    Table 62. Genscript Company Detail
    Table 63. Genscript Business Overview
    Table 64. Genscript Genome Editing and Genome Engineering Product
    Table 65. Genscript Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
    Table 66. Genscript Recent Development
    Table 67. Sangamo Biosciences Company Detail
    Table 68. Sangamo Biosciences Business Overview
    Table 69. Sangamo Biosciences Genome Editing and Genome Engineering Product
    Table 70. Sangamo Biosciences Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
    Table 71. Sangamo Biosciences Recent Development
    Table 72. Integrated DNA Technologies Company Detail
    Table 73. Integrated DNA Technologies Business Overview
    Table 74. Integrated DNA Technologies Genome Editing and Genome Engineering Product
    Table 75. Integrated DNA Technologies Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
    Table 76. Integrated DNA Technologies Recent Development
    Table 77. Lonza Company Detail
    Table 78. Lonza Business Overview
    Table 79. Lonza Genome Editing and Genome Engineering Product
    Table 80. Lonza Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
    Table 81. Lonza Recent Development
    Table 82. New England Biolabs Company Detail
    Table 83. New England Biolabs Business Overview
    Table 84. New England Biolabs Genome Editing and Genome Engineering Product
    Table 85. New England Biolabs Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
    Table 86. New England Biolabs Recent Development
    Table 87. Origene Technologies Company Detail
    Table 88. Origene Technologies Business Overview
    Table 89. Origene Technologies Genome Editing and Genome Engineering Product
    Table 90. Origene Technologies Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
    Table 91. Origene Technologies Recent Development
    Table 92. Transposagen Biopharmaceuticals Company Detail
    Table 93. Transposagen Biopharmaceuticals Business Overview
    Table 94. Transposagen Biopharmaceuticals Genome Editing and Genome Engineering Product
    Table 95. Transposagen Biopharmaceuticals Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
    Table 96. Transposagen Biopharmaceuticals Recent Development
    Table 97. Editas Medicine Company Detail
    Table 98. Editas Medicine Business Overview
    Table 99. Editas Medicine Genome Editing and Genome Engineering Product
    Table 100. Editas Medicine Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
    Table 101. Editas Medicine Recent Development
    Table 102. Crispr Therapeutics Company Detail
    Table 103. Crispr Therapeutics Business Overview
    Table 104. Crispr Therapeutics Genome Editing and Genome Engineering Product
    Table 105. Crispr Therapeutics Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
    Table 106. Crispr Therapeutics Recent Development
    Table 107. Tecan Life Sciences Company Detail
    Table 108. Tecan Life Sciences Business Overview
    Table 109. Tecan Life Sciences Genome Editing and Genome Engineering Product
    Table 110. Tecan Life Sciences Revenue in Genome Editing and Genome Engineering Business (2018-2023) & (US$ Million)
    Table 111. Tecan Life Sciences Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Genome Editing and Genome Engineering Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Genome Editing and Genome Engineering Market Share by Type: 2022 VS 2029
    Figure 3. CRISPR Features
    Figure 4. TALEN Features
    Figure 5. ZFN Features
    Figure 6. Global Genome Editing and Genome Engineering Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 7. Global Genome Editing and Genome Engineering Market Share by Application: 2022 VS 2029
    Figure 8. Cell Line Engineering Case Studies
    Figure 9. Animal Genetic Engineering Case Studies
    Figure 10. Plant Genetic Engineering Case Studies
    Figure 11. Others Case Studies
    Figure 12. Genome Editing and Genome Engineering Report Years Considered
    Figure 13. Global Genome Editing and Genome Engineering Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 14. Global Genome Editing and Genome Engineering Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 15. Global Genome Editing and Genome Engineering Market Share by Region: 2022 VS 2029
    Figure 16. Global Genome Editing and Genome Engineering Market Share by Players in 2022
    Figure 17. Global Top Genome Editing and Genome Engineering Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Genome Editing and Genome Engineering as of 2022)
    Figure 18. The Top 10 and 5 Players Market Share by Genome Editing and Genome Engineering Revenue in 2022
    Figure 19. North America Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. North America Genome Editing and Genome Engineering Market Share by Country (2018-2029)
    Figure 21. United States Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. Canada Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. Europe Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Europe Genome Editing and Genome Engineering Market Share by Country (2018-2029)
    Figure 25. Germany Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. France Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. U.K. Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Italy Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Russia Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Nordic Countries Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Asia-Pacific Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Asia-Pacific Genome Editing and Genome Engineering Market Share by Region (2018-2029)
    Figure 33. China Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Japan Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. South Korea Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Southeast Asia Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. India Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Australia Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Latin America Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Latin America Genome Editing and Genome Engineering Market Share by Country (2018-2029)
    Figure 41. Mexico Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Brazil Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Middle East & Africa Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Middle East & Africa Genome Editing and Genome Engineering Market Share by Country (2018-2029)
    Figure 45. Turkey Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Saudi Arabia Genome Editing and Genome Engineering Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 47. Thermo Fisher Scientific Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
    Figure 48. Merck Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
    Figure 49. Horizon Discovery Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
    Figure 50. Genscript Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
    Figure 51. Sangamo Biosciences Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
    Figure 52. Integrated DNA Technologies Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
    Figure 53. Lonza Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
    Figure 54. New England Biolabs Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
    Figure 55. Origene Technologies Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
    Figure 56. Transposagen Biopharmaceuticals Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
    Figure 57. Editas Medicine Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
    Figure 58. Crispr Therapeutics Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
    Figure 59. Tecan Life Sciences Revenue Growth Rate in Genome Editing and Genome Engineering Business (2018-2023)
    Figure 60. Bottom-up and Top-down Approaches for This Report
    Figure 61. Data Triangulation
    Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS